Unlock stock picks and a broker-level newsfeed that powers Wall Street.
6.48
+0.30
+(4.85%)
At close: April 2 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 8 | 7 |
| Avg. Estimate | -0.84 | -0.83 | -3.37 | -3.06 |
| Low Estimate | -1.03 | -1 | -3.87 | -4.04 |
| High Estimate | -0.67 | -0.62 | -2.47 | -2.36 |
| Year Ago EPS | -0.48 | -1.02 | -3.83 | -3.37 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 8 | 7 |
| Avg. Estimate | 8.59M | 6.79M | 27.47M | 28.45M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 40.1M | 29.3M | 106.2M | 90.6M |
| Year Ago Sales | 56.38M | 3.08M | 74.2M | 27.47M |
| Sales Growth (year/est) | -84.76% | 120.87% | -62.98% | 3.57% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.05 | -0.89 | -1.08 | -0.87 |
| EPS Actual | -0.48 | -1.02 | -1.56 | -0.76 |
| Difference | 0.57 | -0.13 | -0.48 | 0.11 |
| Surprise % | 54.27% | -14.05% | -43.97% | 12.72% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.84 | -0.83 | -3.37 | -3.06 |
| 7 Days Ago | -0.88 | -0.89 | -3.74 | -3.14 |
| 30 Days Ago | -0.88 | -0.89 | -3.74 | -3.14 |
| 60 Days Ago | -0.79 | -0.81 | -3.85 | -3.54 |
| 90 Days Ago | -0.79 | -0.81 | -3.85 | -3.54 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 6 | 5 |
| Up Last 30 Days | -- | -- | 6 | 5 |
| Down Last 7 Days | 1 | 1 | 2 | 1 |
| Down Last 30 Days | 1 | 1 | 2 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| VIR | -75.69% | 18.46% | 12.00% | 9.28% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Maintains | Barclays: Overweight to Overweight | 2/28/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/28/2025 |
| Reiterates | Needham: Buy to Buy | 2/27/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/31/2025 |
| Maintains | Leerink Partners: Outperform to Outperform | 1/13/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/10/2025 |
Related Tickers
JANX Janux Therapeutics, Inc.
28.25
+5.37%
VERV Verve Therapeutics, Inc.
3.9100
-5.44%
EWTX Edgewise Therapeutics, Inc.
15.52
-22.90%
IONS Ionis Pharmaceuticals, Inc.
28.71
+5.32%
QURE uniQure N.V.
10.62
+7.16%
ALNY Alnylam Pharmaceuticals, Inc.
266.83
+4.33%
DNLI Denali Therapeutics Inc.
13.74
+11.80%
RCKT Rocket Pharmaceuticals, Inc.
6.30
+8.43%
ARCT Arcturus Therapeutics Holdings Inc.
10.20
+8.17%
VYGR Voyager Therapeutics, Inc.
3.4100
+1.19%